Researchers improve technology to save sperm stem cells – Science Daily
Yahoo7 News |
Researchers improve technology to save sperm stem cells
Science Daily “If you’re a stem cell that is going to give rise to sperm essentially through the whole lifetime of an individual, you want to have a pristine genome,” said Oatley. “You don’t want it damaged by reactive oxygen species. That’s why we think glycolysis … Scientist’s closer blood cancer treatmentSky News Australia |
The San Diego Union-Tribune |
Public invited to stem cell event in San Diego April 20
The San Diego Union-Tribune Stem cell cures are real, and more are on the way. That’s part of the message California’s stem cell agency will deliver in a special patient advocate event in La Jolla on Thursday, April 20. To be held from noon to 1 p.m., the California Institute for … |
The San Diego Union-Tribune |
California’s stem cell agency invites public to San Diego event April 20
The San Diego Union-Tribune Clinical trials are risky and rely on brave pioneers who are willing to put their bodies on the line to help test the safety and effectiveness of potential new therapies. At its December 2016 meeting, the governing Board of the California Institute for … |
NewHampshire.com |
Stem cell donor registry drive seeks to help retired Brookline teacher
NewHampshire.com Multiple myeloma is a plasma cell disorder that attacks cells in a person’s bone marrow. Since traditional treatments are not working for Kathi Bond, doctors are now looking for radical ways to preserve her life, and a donor transplant is the next … |
OncLive |
Dr. Costin on Frontline Immunotherapy for Patients With NSCLC
OncLive Daniel Costin, MD, hematology and oncology, White Plains Hospital, discusses the potential with immunotherapy agents in the frontline setting as treatment for patients with non–small cell lung cancer (NSCLC). Immunotherapy has become a standard of care … |
|
Foundation Medicine Mining Clinical Sequencing Data for New Determinants of Immunotherapy Response
GenomeWeb As immunotherapy has rapidly gained ground in the oncology community, research has accelerated in tandem to identify molecular markers or signatures that can best predict which patients may benefit. “It likely hasn’t escaped the attention of [attendees … |